Intelligent Bio Solutions (INBS) rises 20.58% intraday after ISO 13485:2016 recertification

ByAinvest Wire

Monday, Aug 17, 2026 9:56 am ET1min read

Intelligent Bio Solutions (INBS) shares rose 20.58% in intraday trading after the company announced its Intelligent Fingerprinting Drug Screening business has been recertified to the ISO 13485:2016 quality management system standard by the British Standards Institution. This recertification aligns with the FDA's amended Quality Management System Regulation and supports the company's regulatory strategy as it pursues FDA clearance for its drug screening system.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Intelligent Bio Solutions (INBS) rises 20.58% intraday after ISO 13485:2016 recertification

Stay ahead of the market.

Comments

AInvestPRO

AInvest

AInvest
PRO